Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrei Sarlea
Andrei Sarlea
Boston Children's Hospital
Eculizumab
Alternative complement pathway
Immunology
Biology
Complement component C5
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment.
2020
Cellular & Molecular Immunology
Lambertus P. van den Heuvel
Nicole C. A. J. van de Kar
Caroline Duineveld
Andrei Sarlea
Thea J. A. M. van der Velden
Wilhelmus T. B. Liebrand
Sanne van Kraaij
Camilla Schjalm
Romy N Bouwmeester
Jack F.M. Wetzels
Tom Eirik Mollnes
Elena Volokhina
Show All
Source
Cite
Save
Citations (4)
Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
2020
British Journal of Clinical Pharmacology
Gaby A.M. Eliesen
Joris van Drongelen
Petra H.H. van den Broek
Andrei Sarlea
Olivier W.H. van der Heijden
Saskia Langemeijer
Rick Greupink
Elena B. Volokhina
Frans G. M. Russel
Show All
Source
Cite
Save
Citations (1)
1